Benzinga | Aug 11, 2021 08:33AM EDT

Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $255

Stephens & Co. analyst Chris Cooley maintains Steris (NYSE:STE) with a Overweight and raises the price target from $217 to $255.